What Products Will Drive the Most Growth in the Biologicals Market in the Next 10 Years?

A panel of Brazilian thought leaders share their well-informed perspectives on the new law and its widespread implications.

The transaction includes the Novartis repository of natural compounds and genetic strains for agricultural use.

Experts share insight on whether any actual improvements have been made with regulations for biologicals in Europe.

The future of biologicals is bright, but companies must prove their value with solid science, strong business cases, and a clear go-to-market strategy.

Executives offer their views on investment expectations for biologicals in the short to medium term.

Dias will oversee a key region for the group and focus on strengthening and expanding Rovensa Next’s portfolio of biosolutions.

From formulation to manufacturing, experts share their insight on where we can expect the industry’s greatest innovations.

Launching biological products in the EU faces significant hurdles, primarily due to a complex regulatory system and market fragmentation.

AgriBusiness Global talked with experts to get tips on creating a strong strategy to bring your biological innovations to North American markets.